KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Novartis Ag (NVS) Equity Ratio (2017 - 2025)

Novartis Ag (NVS) has disclosed Equity Ratio for 9 consecutive years, with 0.42 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 3.66% to 0.42 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.42 through Dec 2025, down 3.66% year-over-year, with the annual reading at 0.42 for FY2025, 3.66% down from the prior year.
  • Equity Ratio hit 0.42 in Q4 2025 for Novartis Ag, down from 0.43 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.51 in Q4 2021 to a low of 0.42 in Q4 2025.
  • Historically, Equity Ratio has averaged 0.47 across 5 years, with a median of 0.47 in 2023.
  • Biggest five-year swings in Equity Ratio: soared 4733.89% in 2021 and later fell 7.74% in 2024.
  • Year by year, Equity Ratio stood at 0.51 in 2021, then dropped by 1.69% to 0.51 in 2022, then decreased by 7.55% to 0.47 in 2023, then dropped by 7.74% to 0.43 in 2024, then dropped by 3.66% to 0.42 in 2025.
  • Business Quant data shows Equity Ratio for NVS at 0.42 in Q4 2025, 0.43 in Q4 2024, and 0.47 in Q4 2023.